Source: Shaker, M. R., et al. Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro. J. Vis. Exp. (2022).
This video demonstrates the transformation of human pluripotent stem cells (hPSCs) into spherical brain organoids. By using specific inhibitors, the hPSCs are guided to differentiate towards a neuronal lineage, forming neuroectodermal colonies. Special growth factors are then introduced, which encourage the self-organization and proliferation of the colonies, ultimately leading to the formation of spherical brain organoids.
1. Cortical brain organoid generation (Figure 1)
NOTE: All the steps in this section of the protocol will occur in a Class 2 biosafety hood unless stated otherwise.
Table 1: N2 Medium. The table lists the reagents required to prepare the N2 medium.
Media components | Concentration |
DMEM Nutrient mix F12 10x 500 mL (DMEM/F-12) | |
N2 Supplement 5 mL (100x) | Supplmented at 1% |
B 27 Supplement 10 mL | Supplemented at 2% |
MEM Non-Essential Amino Acids Solution (100x) | Supplemented at 1% |
Penicillin-Streptomycin (10,000 U/mL) | Supplemented at 1% |
2-Mercaptoethanol 50 mL(1000x ) | Supplemented at 0.1% |
Figure 1: Schematic diagram for generating reproducible cortical brain organoids. Schematic workflow of the experimental procedure for the generation of cortical brain organoids from hPSCs maintained in the feeder-free medium. The workflow provides an overview of six steps involved in differentiating the 2D hPSCs into 3D patterned cortical plate human tissues in organoids.
The authors have nothing to disclose.
16% Formaldehyde (W/V) Methanol-free | Thermo Fisher Scientific | 28908 | 4% of PFA are diluted in 1x PBS |
2-Mercaptoethanol 50 mL(1000x) | Life Technologies Australia (TFS) | 21985023 | Used in NM and DM media |
B 27 Supplement 10 mL | Life Technologies Australia (TFS) | 17504044 | Used in NM and DM media |
CKX53 microscope with SC50 camera | Olympus | ||
Corning Costar 6 well cell culture plates | Sigma Aldrich Pty Ltd | CLS3516-50EA | |
Dispase II powder | Thermo Fisher Scientific | 17105041 | Powder is dissolve in HBSS, filtered through 0.22 µm filter, aliquote at 10 mL and store at -20 °C |
DMEM Nutrient Mix F12 10x 500 mL (DMEM/F-12) | Thermofisher | 11320082 | Used in NM and DM media |
DMSO Dimethyl Sulfoxide | Sigma Aldrich Pty Ltd | D2650-100ML | |
Dulbecco's Phosphate Buffered Saline | Sigma Aldrich Pty Ltd | D1408-500ML | |
Falcon Matrigel hESC-qualified Matrix | In Vitro Technologies Pty Ltd | FAL354277 | Make aliquotes of 100 µL and stored at -20 °C |
GlutaMAX Supplement 100x | Thermo Fisher Scientific | 35050061 | Used in NM and DM media |
Hanks Balanced Salt Solution | Sigma Aldrich Pty Ltd | H8264 | |
Human induced pluripotent stem cells (EU79) | In-house reporogrammed from skin fibroblast | ||
Human induced pluripotent stem cells (G22) | Genea Biocells | Obtained from Genea Biocells (San Diego, United States) | |
Human induced pluripotent stem cells (WTC) | Gift from Professor Bruce Conklin | ||
InSolution TGF-Β RI Kinase Inhibitor VI, SB431542 | Merck | US1616464-5MG | |
Insulin Solution Human Recombinant | Sigma Aldrich Pty Ltd | I9278 | Used in NM and DM media |
LDN193189 Dihydrochloride | Sigma Aldrich Pty Ltd | SML0559-5MG | Used during differentiation |
MEM Non-Essential Amino Acids Solution (100x) | Thermo Fisher Scientific | 11140050 | Used in NM and DM media |
mTeSR Plus | STEMCELL TECHNOLOGIES | 100-0276 | Used to maintain hiPSC colonies prior to differentiation with NM media |
N2 Supplement 5 mL (100x) | Life Technologies Australia Pty Ltd | 17502048 | Used in NM and DM media |
Penicillin-Streptomycin (10,000 U/mL) | Thermo Fisher Scientific | 15140122 | Used in NM and DM media |
Recombinant Human FGF basic | R&D Systems | 233-FB-01M | Aliquots are made at 20 µg/mL and stored at -20 °C |
SB431542 | Tocris | 1614 | Used during differentiation |
Ultra-Low attachment multiwell plates, 24-well plate, polystyrene | Sigma Aldrich Pty Ltd | CLS3473-24EA |